Trustmark National Bank Trust Department Lowered Its Johnson And Johnson (JNJ) Stake; Owens & Minor (OMI) Sellers Increased By 3.47% Their Shorts

January 19, 2018 - By Michael Collier

Owens & Minor Incorporated (NYSE:OMI) had an increase of 3.47% in short interest. OMI’s SI was 7.66 million shares in January as released by FINRA. Its up 3.47% from 7.40 million shares previously. With 1.37M avg volume, 6 days are for Owens & Minor Incorporated (NYSE:OMI)’s short sellers to cover OMI’s short positions. The SI to Owens & Minor Incorporated’s float is 12.74%. The stock decreased 0.57% or $0.12 during the last trading session, reaching $21.07. About 459,939 shares traded. Owens & Minor, Inc. (NYSE:OMI) has declined 11.64% since January 19, 2017 and is downtrending. It has underperformed by 28.34% the S&P500.

Trustmark National Bank Trust Department decreased Johnson And Johnson (JNJ) stake by 14.94% reported in 2017Q3 SEC filing. Trustmark National Bank Trust Department sold 8,120 shares as Johnson And Johnson (JNJ)’s stock rose 6.85%. The Trustmark National Bank Trust Department holds 46,243 shares with $6.01M value, down from 54,363 last quarter. Johnson And Johnson now has $394.77B valuation. The stock increased 0.02% or $0.03 during the last trading session, reaching $146.95. About 2.20M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 19, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 86 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Tuesday, September 29 by Deutsche Bank. The firm has “Equal-Weight” rating given on Wednesday, October 18 by Barclays Capital. The stock of Johnson & Johnson (NYSE:JNJ) earned “Outperform” rating by Cowen & Co on Tuesday, August 25. Barclays Capital downgraded the stock to “Equal-Weight” rating in Tuesday, November 29 report. Morgan Stanley maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, October 18 with “Equal-Weight” rating. Argus Research maintained it with “Buy” rating and $165 target in Wednesday, October 18 report. The firm earned “Buy” rating on Wednesday, October 11 by Jefferies. The company was downgraded on Friday, July 21 by Atlantic Securities. RBC Capital Markets maintained it with “Outperform” rating and $114 target in Wednesday, October 7 report. The firm earned “Neutral” rating on Wednesday, April 20 by Goldman Sachs.

Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It is without change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Washington has 111,014 shares. Daniel Devine & has 3.62% invested in Johnson & Johnson (NYSE:JNJ) for 36,407 shares. Alps Incorporated reported 0.32% of its portfolio in Johnson & Johnson (NYSE:JNJ). New York-based Douglass Winthrop Advsrs has invested 1.49% in Johnson & Johnson (NYSE:JNJ). Leavell Investment Mgmt Incorporated, Alabama-based fund reported 41,741 shares. Halbert Hargrove Russell Limited Liability Corp owns 3,446 shares for 0.12% of their portfolio. Bank owns 18,299 shares. Pictet Asset has invested 0.65% in Johnson & Johnson (NYSE:JNJ). Centre Asset Limited Liability Corp has 3.05% invested in Johnson & Johnson (NYSE:JNJ). First Foundation, a California-based fund reported 257,639 shares. 798,932 are held by Tekla Mngmt Ltd Company. Great West Life Assurance Can, a Manitoba – Canada-based fund reported 3.88 million shares. Bedrijfstakpensioenfonds Voor De Media Pno has 0.78% invested in Johnson & Johnson (NYSE:JNJ). Snow Mngmt Lp reported 0.02% stake. Davenport And Co Limited Liability Company has 2.3% invested in Johnson & Johnson (NYSE:JNJ).

Trustmark National Bank Trust Department increased Powershares (PZA) stake by 126,942 shares to 2.03 million valued at $51.83 million in 2017Q3. It also upped Glaxosmithkline Plc (NYSE:GSK) stake by 26,019 shares and now owns 40,350 shares. Powershares (PSP) was raised too.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 earnings per share, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62 billion for 21.36 P/E if the $1.72 EPS becomes a reality. After $1.90 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.

Among 9 analysts covering Owens & Minor (NYSE:OMI), 0 have Buy rating, 5 Sell and 4 Hold. Therefore 0 are positive. Owens & Minor had 15 analyst reports since August 25, 2015 according to SRatingsIntel. The rating was downgraded by Zacks on Tuesday, August 25 to “Hold”. RBC Capital Markets maintained it with “Sector Perform” rating and $36 target in Monday, December 7 report. The rating was upgraded by Robert W. Baird on Friday, September 1 to “Neutral”. As per Wednesday, January 17, the company rating was maintained by Robert W. Baird. JP Morgan downgraded Owens & Minor, Inc. (NYSE:OMI) on Tuesday, December 19 to “Underweight” rating. The firm has “Underperform” rating by Credit Suisse given on Monday, November 20. The firm has “Hold” rating given on Monday, September 11 by Jefferies. The firm has “Hold” rating by Jefferies given on Friday, July 7. The company was initiated on Thursday, October 6 by UBS. Robert W. Baird downgraded Owens & Minor, Inc. (NYSE:OMI) on Thursday, April 21 to “Underperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: